Detalhe da pesquisa
1.
Phase 3 trial of gilteritinib plus azacitidine vs azacitidine for newly diagnosed FLT3mut+ AML ineligible for intensive chemotherapy.
Blood
; 140(17): 1845-1857, 2022 10 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-35917453
2.
Cerebrospinal fluid soluble programmed death-ligand 1 is a useful prognostic biomarker in primary central nervous system lymphoma.
Br J Haematol
; 201(1): 75-85, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36480431
3.
A three-gene leukaemic stem cell signature score is robustly prognostic in chronic myelomonocytic leukaemia.
Br J Haematol
; 201(2): 302-307, 2023 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36746431
4.
Signal peptide-CUB-EGF-like repeat-containing protein 1-promoted FLT3 signaling is critical for the initiation and maintenance of MLL-rearranged acute leukemia.
Haematologica
; 108(5): 1284-1299, 2023 05 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36005562
5.
Distinct genetic landscapes and their clinical implications in younger and older patients with myelodysplastic syndromes.
Hematol Oncol
; 41(3): 463-473, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36420747
6.
Risk factors for thromboembolic events in patients with paroxysmal nocturnal hemoglobinuria (PNH): a nested case-control study in the International PNH Registry.
Ann Hematol
; 102(11): 2979-2988, 2023 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-37668788
7.
Evaluation of the clinical significance of global mRNA alternative splicing in patients with acute myeloid leukemia.
Am J Hematol
; 98(5): 784-793, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36855936
8.
Clinico-genetic and prognostic analyses of 716 patients with primary myelodysplastic syndrome and myelodysplastic syndrome/acute myeloid leukemia based on the 2022 International Consensus Classification.
Am J Hematol
; 98(3): 398-407, 2023 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-36588411
9.
Validation of the prognostic significance of the 2022 European LeukemiaNet risk stratification system in intensive chemotherapy treated aged 18 to 65 years patients with de novo acute myeloid leukemia.
Am J Hematol
; 98(5): 760-769, 2023 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36861732
10.
The clinical and biological characterization of acute myeloid leukemia patients with S100A4 overexpression.
J Formos Med Assoc
; 122(7): 636-647, 2023 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-36428148
11.
Epidemiology and survival outcomes of acute myeloid leukemia patients in Taiwan: A national population-based analysis from 2001 to 2015.
J Formos Med Assoc
; 122(6): 505-513, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36369106
12.
Atypical hemolytic uremic syndrome: Consensus of diagnosis and treatment in Taiwan.
J Formos Med Assoc
; 122(5): 366-375, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-36323601
13.
Immune signatures of bone marrow cells can independently predict prognosis in patients with myelodysplastic syndrome.
Br J Haematol
; 196(1): 156-168, 2022 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34536013
14.
Gilteritinib or Chemotherapy for Relapsed or Refractory FLT3-Mutated AML.
N Engl J Med
; 381(18): 1728-1740, 2019 10 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-31665578
15.
Effectiveness of induction regimens on survival outcome in acute myeloid leukemia patients: a real-world data from 2001 to 2015.
Ann Hematol
; 101(1): 109-118, 2022 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-34643769
16.
Polatuzumab vedotin-based salvage immunochemotherapy as third-line or beyond treatment for patients with diffuse large B-cell lymphoma: a real-world experience.
Ann Hematol
; 101(2): 349-358, 2022 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-34766217
17.
Effect of mutation allele frequency on the risk stratification of myelodysplastic syndrome patients.
Am J Hematol
; 97(12): 1589-1598, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36109871
18.
Bone marrow plasma level of decorin may be associated with improved treatment outcomes in a subset of multiple myeloma patients.
J Formos Med Assoc
; 121(3): 643-651, 2022 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34246509
19.
The expression levels of long non-coding RNA KIAA0125 are associated with distinct clinical and biological features in myelodysplastic syndromes.
Br J Haematol
; 192(3): 589-598, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33249572
20.
Genomic landscape and clonal evolution of acute myeloid leukemia with t(8;21): an international study on 331 patients.
Blood
; 133(10): 1140-1151, 2019 03 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30610028